Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  maytansine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-22 of 22 for your search:
Start Over
Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 14 to 75
Sponsor: NCI
Protocol IDs: EST-3377
Phase I-II Chemotherapy with Maytansine for Solid Tumors and Hematologic Malignancies
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7608
Phase II Chemotherapy with Maytansine for Acute Leukemia in Children
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-7819, MDAR-324
Phase II Chemotherapy with Maytansine for Refractory Solid Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-78ST222, SEG-78ST0102
Phase II Chemotherapy with Maytansine for Malignant Disease
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-77015
Phase II Chemotherapy with Maytansine for Advanced Breast Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7809
Phase II Chemotherapy with Maytansine for Advanced Sarcoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7820
Phase II Chemotherapy with Maytansine for Advanced Hodgkin's and non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7821
Phase II Chemotherapy with Maytansine for Squamous Cell Carcinoma of the Lung
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7708
Phase II Chemotherapy with Maytansine for Advanced Malignant Disease
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-24077
Phase II Evaluation of Maytansine for Unresectable, Recurrent, or Metastatic Islet Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-824401
Phase II Pilot Study of Maytansine in Patients with Hodgkin's and non-Hodgkin's Lymphomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PA-477
Phase II Master Protocol and Chemotherapy with cis-Platinum, Maytansine, or Chlorozotocin for Advanced Small Cell Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2578
Phase II Chemotherapy with Maytansine for Advanced Recurrent Pelvic Malignancies
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-26H
A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- SMF (SZC/MITO/5-FU), MTS
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9376B
Phase II Evaluation of Maytansine in Advanced Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-772501
Phase II Chemotherapy with Maytansine or Chlorozotocin for Advanced Breast Cancer with Crossover Upon Progression
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-773202
Phase II Chemotherapy with Maytansine for Advanced Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-774601
Phase II Chemotherapy with Maytansine or Streptozotocin for Disseminated Melanoma with Crossover Upon Progression
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-777001A
Phase II Chemotherapy with Maytansine or Chlorozotocin for Disseminated Melanoma with Crossover Upon Progression
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-777001B
Phase II Chemotherapy with CTX/ADR/CACP Followed Upon Failure by Maytansine for Advanced Head and Neck Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-777401
Phase II Chemotherapy with Maytansine for Melanoma and Breast Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7728
Start Over